BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Samy RN, Earl BR, Lipschitz N, Schweinzger I, Currier M, Cripe T. Engineered oncolytic virus for the treatment of cholesteatoma: A pilot in vivo study. Laryngoscope Investig Otolaryngol 2019;4:532-42. [PMID: 31637298 DOI: 10.1002/lio2.307] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Uzun T, Çaklı H, Coşan DT, İncesulu ŞA, Kaya E, Çalış İU, Yıldız E. In vitro study on immune response modifiers as novel medical treatment options for cholesteatoma. Int J Pediatr Otorhinolaryngol 2021;145:110743. [PMID: 33933986 DOI: 10.1016/j.ijporl.2021.110743] [Reference Citation Analysis]
2 Lipschitz N, Earl BR, Cripe TP, Samy RN. Oncolytic virotherapy: a potential therapeutic approach for cholesteatoma. Curr Opin Otolaryngol Head Neck Surg 2020;28:281-5. [PMID: 32833886 DOI: 10.1097/MOO.0000000000000651] [Reference Citation Analysis]